3655
-
OncoTargets and Therapy
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Real benefits for authors, including fast-track processing of papers.
OncoTargets and Therapy
(112,565) Views
Editor in Chief Professor Hans-Joachim Schmoll
1178-6930
Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer managementAnn Gramza, Kathryn G Schuff
Topotecan in the treatment of relapsed small cell lung cancer
Elisabeth Quoix
Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling
Wessen Maruwge, Pádraig D’Arcy, Annika Folin, Slavica Brnjic, Johan Wejde, et al
Refining targeted therapies in chronic myeloid leukemia: development and application of nilotinib, a step beyond imatinib
Massimo Breccia, Giuliana Alimena
Polyclonal B-cell lymphocytosis with binucleated lymphocytes (PPBL)
Xavier Troussard, Edouard Cornet, Jean-François Lesesve, Carine Kourel, Hossein Mossafa
Relationship between arachidonic acid pathway and human renal cell carcinoma
Masahide Matsuyama, Rikio Yoshimura
The efficacy and safety of irinotecan cisplatin and mitomycin chemotherapy in sunitinib pre-treated metastatic clear cell renal cancer
Thomas Powles, Siobhan McFaul, Justin Stebbing, Peter Wilson, Tim Oliver et al
Targeted treatment of advanced and metastatic breast cancer with lapatinib
Brendan Corkery, Norma O’Donovan, John Crown
The epidermal growth factor receptor family in breast cancer
Angelos K Koutras, T R Jeffry Evans
Incompletely excised basal cell carcinomas: Our guidelines
P Longhi, M Paola Serra, E Robotti
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
